| Press Releases |
| Q&M Dental Enhances its Digital Capabilities by Integrating Align Technology's Newest iTero Lumina(TM) Intraoral Scanner Across Dental Clinics in Singapore
4/29/2024 |
| CanSinoBIO CSO Shares Latest Results of the Company's Globally Innovative Pneumococcal Vaccine
4/26/2024 |
| Elevate Your Sleep Game This World Health Day with LAC
4/25/2024 |
| OrbusNeich's Joint Venture Kicks Off TricValve Clinical Trial in Mainland China
4/24/2024 |
| Dogs Thrive on Vegan Diets, Demonstrates the Most Comprehensive Study So Far
4/24/2024 |
| China Medical System: New Drug Application of Desidustat Tablets Accepted in China
4/23/2024 |
| New Contaminants, Food Testing & More: analytica Convention 2024 Focuses on Vietnam's Laboratory Needs
4/23/2024 |
| EM2AI Revolutionising the Dental Industry: New AI Products Promise Transparent Treatment Plans for Patients
4/23/2024 |
| Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25
4/19/2024 |
| DC Healthcare Rides the Wave of Success with New Openings at Publika and Bukit Indah
4/18/2024 |
| Eisai: Research on Treatments for Alzheimer's Disease Based on Its Pathological Mechanisms Recieves Award for Science and Technology (Research Category)
4/18/2024 |
| Eisai's Antiepileptic Drug Fycompa Injection Formulation Launched In Japan
4/17/2024 |
| SinoMab BioScience preclinical results of SM17 on atopic dermatitis (AD) published on International Scientific Journal Allergy
4/16/2024 |
| Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology
4/16/2024 |
| Chiron AS in Trondheim, Norway, Has Developed The World's First Commercial Microplastic Reference Materials
4/9/2024 |
| BYND Cannasoft Announces RSU Grant
4/8/2024 |
| The $7 Billion CBD Market in 2023 is Focused on Significant Growth in Personal Care
4/5/2024 |
| World Hepatitis Summit 2024 Convenes in Lisbon
4/4/2024 |
| A $45 Billion Dollars Market is in the Crosshairs of BYND Cannasoft with a New Series of Concept Smart Fem-Tech Devices
4/3/2024 |
| Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization
4/3/2024 |
| French Sales Subsidiary Eisai S.A.S. to Divest Rights for Loxapac And Parkinane LP to CNX Therapeutics
4/3/2024 |
| Israeli Technology Company BYND Cannasoft Enterprises Inc. Announces Financial Results For The Year Ended December 31, 2023
4/3/2024 |
| CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
4/1/2024 |
| Eisai Completes Submission of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA
4/1/2024 |
| Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical
3/29/2024 |
| Eisai's Brain Health Self-Check Tool "NouKNOW" is Certified as "ME-BYO BRAND" by Kanagawa Prefecture
3/29/2024 |
| Eisai: Discovery Research on Dual Orexin Receptor Antagonist Lemborexant Honored with PSJ Award for Drug Research and Development 2024
3/29/2024 |
| Sino Biopharm (1177.HK) Announces 2023 Annual Results
3/29/2024 |
| Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study
3/28/2024 |
| China Medical System (867.HK) 2023 Annual Results: Despite of the Temporary Financial Performance Pressure, Fresh Catalysts Emerged from Successive Innovation Breakthroughs
3/28/2024 |
| The Commercialization of Asia's First Meningococcal Conjugate Vaccine From CanSinoBIO Represents a Significant Breakthrough
3/27/2024 |
| NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System
3/27/2024 |
| BYND Cannasoft Provides Business Update
3/26/2024 |
| Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine
3/26/2024 |
| Early Warning News Release for Yftah Ben Yaacov and Carmel Zigdon
3/26/2024 |
| DC Healthcare Continues Growth Momentum with Second DC Body Outlet Opening in USJ Taipan
3/25/2024 |
| Lifenet and Eisai Co-Develop Dementia Insurance "be"
3/21/2024 |
| Eisai Selected as a Nadeshiko Brand 2024 as a Listed Company Excelling in Promotion of Women in the Workplace
3/21/2024 |
| Avantor Wins Five Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2024
3/21/2024 |
| Neusoft Xikang Holdings Inc. Releases 2023 Annual Results, Business Structure Gradually Optimized, Share of Medical Services Business Continued to Grow
3/21/2024 |
| Essex Bio-Technology Posts Sound 2023 Annual Financial Results, Revenue Up 29.5%, Profit Up 22.1%
3/18/2024 |
| GERMAGIC(TM) PET Hosts "Social Inclusion Charity Run with Pets"
3/18/2024 |
| BYND Cannasoft Enterprises Inc. Announces Reverse Split
3/15/2024 |
| BYND Cannasoft Enterprises Inc. Announces Closing of $7.0 Million Underwritten Public Offering
3/15/2024 |
| APEL Biomedical Technology Innovation and Translational Commercial Laboratory Officially Opens
3/13/2024 |
| BYND Cannasoft Enterprises Inc. Announces Voluntary Delisting from Canadian Securities Exchange
3/13/2024 |
| BYND Cannasoft Enterprises Inc. Announces Pricing of $7.0 Million Underwritten Public Offering
3/12/2024 |
| CGFNS International and The DAISY Foundation Honor Outstanding International Nurse Recruiters
3/12/2024 |
| OrbusNeich Achieves Record-High Revenue and Net Profit of US$154 Million and US$45.1 Million Respectively, Recommends Final Dividend Payment of HK10 cents per Share
3/7/2024 |
| Eisai Invests in C2N to Support Simplifying the Diagnosis of Early Alzheimer's Disease to Better Serve Patients
3/6/2024 |
